SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 5,200 shares, a decrease of 56.7% from the September 30th total of 12,000 shares. Based on an average daily trading volume, of 9,800 shares, the days-to-cover ratio is presently 0.5 days.
SAB Biotherapeutics Stock Performance
Shares of SABSW stock remained flat at $0.05 during trading hours on Friday. 12,095 shares of the stock traded hands, compared to its average volume of 19,374. The business’s fifty day moving average is $0.03 and its two-hundred day moving average is $0.04. SAB Biotherapeutics has a 52-week low of $0.01 and a 52-week high of $0.19.
About SAB Biotherapeutics
See Also
- Five stocks we like better than SAB Biotherapeutics
- The Significance of Brokerage Rankings in Stock Selection
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- 3 REITs to Buy and Hold for the Long Term
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for SAB Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SAB Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.